Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Angiodynamics Inc Issues Q3 2013 Guidance Below Analysts' Estimates

Thursday, 7 Mar 2013 04:30pm EST 

Angiodynamics Inc announced that it expects to report net sales for the third quarter of 2013 to be approximately $82 million and expects to report adjusted net income for the third quarter in the range of $0.04 per share to $0.06 per share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues $89 million and EPS of $0.09 for the third quarter of 2013. 

Company Quote

-0.34 -2.40%
20 Aug 2014